中医药治疗再生障碍性贫血的研究进展
The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia.
作者信息
Zhu Ningning, Wu Dijiong, Ye Baodong
机构信息
First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.
Department of Hematology, First Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang Province, China.
出版信息
J Transl Int Med. 2018 Dec 31;6(4):159-164. doi: 10.2478/jtim-2018-0031. eCollection 2018 Dec.
Abstract
Aplastic anemia (AA) is a common hematologic disease that is characterized by hematopoietic failure of the bone marrow and pancytopenia of the peripheral blood, which can be divided into severe and non-severe aplastic ane-mia, or acute and chronic aplastic anemia according to the severity of the disease and the progress of the clinical course. During the past years, the advantages of Traditional Chinese Medicine (TCM) on the treatment of AA have been well clarified and its theory system has been improved as well. This review is mainly on representing the pathogenesis, therapeutic principle and method, research progression, and advantages of TCM on AA.
摘要
再生障碍性贫血（AA）是一种常见的血液系统疾病，其特征为骨髓造血功能衰竭和外周血全血细胞减少，根据疾病严重程度和临床病程进展可分为重型和非重型再生障碍性贫血，或急性和慢性再生障碍性贫血。在过去几年中，中医药治疗AA的优势已得到充分阐明，其理论体系也得到了完善。本综述主要阐述中医药治疗AA的发病机制、治疗原则和方法、研究进展及优势。
相似文献
1
The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia.中医药治疗再生障碍性贫血的研究进展
J Transl Int Med. 2018 Dec 31;6(4):159-164. doi: 10.2478/jtim-2018-0031. eCollection 2018 Dec.
2
Traditional Chinese medicine for treating aplastic anemia.中药治疗再生障碍性贫血。
J Pharm Pharm Sci. 2023 Nov 13;26:11863. doi: 10.3389/jpps.2023.11863. eCollection 2023.
3
Special Education: Aplastic Anemia.特殊教育：再生障碍性贫血。
Oncologist. 1996;1(3):187-189.
4
Research progress on the hematopoietic microenvironment in aplastic anemia.再生障碍性贫血造血微环境的研究进展。
Eur J Haematol. 2023 Aug;111(2):172-180. doi: 10.1111/ejh.13991. Epub 2023 May 19.
5
Aplastic Anemia in China.中国的再生障碍性贫血
J Transl Int Med. 2018 Oct 9;6(3):134-137. doi: 10.2478/jtim-2018-0028. eCollection 2018 Sep.
6
Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.中国再生障碍性贫血的现行治疗模式：一项前瞻性队列研究。
Acta Haematol. 2019;142(3):162-170. doi: 10.1159/000499065. Epub 2019 May 15.
7
Idiopathic aplastic anemia: diagnosis and classification.特发性再生障碍性贫血：诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):569-73. doi: 10.1016/j.autrev.2014.01.014. Epub 2014 Jan 12.
8
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility.获得性再生障碍性贫血中的间充质干细胞：从基础到临床应用的范围。
Int J Mol Sci. 2023 Feb 24;24(5):4464. doi: 10.3390/ijms24054464.
9
[Establishing aplastic anemia animal model based on different pathogenesis].基于不同发病机制建立再生障碍性贫血动物模型
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Feb;23(1):285-9. doi: 10.7534/j.issn.1009-2137.2015.01.054.
10
Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.获得性再生障碍性贫血：病因、病理生理学、骨髓组织学与预后因素之间的相关性
Rom J Morphol Embryol. 2009;50(4):669-74.
引用本文的文献
1
Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice MAPK pathway.人参皂苷Rg1对小鼠再生障碍性贫血造血干细胞的影响 MAPK通路。
World J Stem Cells. 2024 May 26;16(5):591-603. doi: 10.4252/wjsc.v16.i5.591.
2
Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.Haploidentical 造血干细胞移植作为儿科重型再生障碍性贫血一线治疗：单中心研究。
Int J Med Sci. 2024 Apr 15;21(6):1027-1036. doi: 10.7150/ijms.94012. eCollection 2024.
3
Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.网络药理学与实验验证二仙汤治疗再生障碍性贫血的潜在机制。
Sci Rep. 2023 Oct 13;13(1):17385. doi: 10.1038/s41598-023-44672-9.
4
Medication Regularity of Traditional Chinese Medicine in the Treatment of Aplastic Anemia Based on Data Mining.基于数据挖掘的中医药治疗再生障碍性贫血用药规律研究
Evid Based Complement Alternat Med. 2022 Aug 25;2022:1605359. doi: 10.1155/2022/1605359. eCollection 2022.
5
Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias.中药疗法对台湾遗传性溶血性贫血患者全因死亡、糖尿病相关死亡和心血管疾病相关死亡风险的影响。
Front Pharmacol. 2022 May 30;13:891729. doi: 10.3389/fphar.2022.891729. eCollection 2022.
6
Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-B Signaling Pathway.配方通过抑制PI3K/AKT/NF-κB信号通路的表达减轻免疫介导的再生障碍性贫血小鼠模型的骨髓抑制。
Evid Based Complement Alternat Med. 2022 Apr 14;2022:9033297. doi: 10.1155/2022/9033297. eCollection 2022.
7
Effects of Sodium Chlorophyllin Copper on APO-1 Expression in Bone Marrow Mesenchymal Stem Cells of Rats with Aplastic Anaemia.叶绿素铜钠盐对再生障碍性贫血大鼠骨髓间充质干细胞 APO-1 表达的影响。
J Immunol Res. 2022 Apr 6;2022:6792866. doi: 10.1155/2022/6792866. eCollection 2022.
8
Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis.环孢素单药治疗非重型再生障碍性贫血患儿：一项回顾性分析
Front Med (Lausanne). 2022 Mar 7;9:805197. doi: 10.3389/fmed.2022.805197. eCollection 2022.
9
Differentiation of Yin, Yang and Stasis Syndromes in Severe Aplastic Anemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Correlation with Iron Metabolism, cAMP/cGMP, 17-OH-CS and Thyroxine.重型再生障碍性贫血患者异基因造血干细胞移植中阴阳瘀证的辨治及其与铁代谢、环磷酸腺苷/环磷酸鸟苷、17-羟皮质类固醇和甲状腺素的相关性
J Blood Med. 2021 Nov 13;12:975-989. doi: 10.2147/JBM.S332171. eCollection 2021.
10
Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan.中药疗法降低再生障碍性贫血患者的总体死亡风险和贫血相关死亡风险：台湾一项全国性回顾性研究
Front Pharmacol. 2021 Oct 8;12:730776. doi: 10.3389/fphar.2021.730776. eCollection 2021.
本文引用的文献
1
Aplastic anemia is related to alterations in T cell receptor signaling.再生障碍性贫血与T细胞受体信号传导的改变有关。
Stem Cell Investig. 2017 Oct 24;4:85. doi: 10.21037/sci.2017.09.07. eCollection 2017.
2
Efficacy and advantages of modified Traditional Chinese Medicine treatments based on "kidney reinforcing" for chronic aplastic anemia: a randomized controlled clinical trial.基于“补肾”的改良中医治疗慢性再生障碍性贫血的疗效及优势：一项随机对照临床试验
J Tradit Chin Med. 2016 Aug;36(4):434-43. doi: 10.1016/s0254-6272(16)30059-0.
3
[Chinese expert consensus on the diagnosis and treatment of aplastic anemia (2017)].再生障碍性贫血诊断与治疗中国专家共识（2017年版）
Zhonghua Xue Ye Xue Za Zhi. 2017 Jan 14;38(1):1-5. doi: 10.3760/cma.j.issn.0253-2727.2017.01.001.
4
Guidelines for the diagnosis and management of adult aplastic anaemia.成人再生障碍性贫血诊断与治疗指南。
Br J Haematol. 2016 Jan;172(2):187-207. doi: 10.1111/bjh.13853. Epub 2015 Nov 16.
5
The complex pathophysiology of acquired aplastic anaemia.获得性再生障碍性贫血的复杂病理生理学。
Clin Exp Immunol. 2015 Jun;180(3):361-70. doi: 10.1111/cei.12605. Epub 2015 Apr 23.
6
Fas/FasL in the immune pathogenesis of severe aplastic anemia.Fas/FasL在重型再生障碍性贫血免疫发病机制中的作用
Genet Mol Res. 2014 May 30;13(2):4083-8. doi: 10.4238/2014.May.30.3.
7
Effect of kidney-reinforcing, blood-activating and stasis-removing recipes on adhesion molecule expression of bone marrow mesenchymal stem cells from chronic aplastic anemia patients.补肾活血祛瘀方对慢性再生障碍性贫血患者骨髓间充质干细胞黏附分子表达的影响。
J Tradit Chin Med. 2012 Dec;32(4):596-603. doi: 10.1016/s0254-6272(13)60077-1.
8
[Proposal on the standardized name of commonly encountered hematological diseases and syndromes in Chinese medicine].[关于常见血液病中医病名和证候规范名称的建议]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Nov;29(11):1040-1.
9
Aplastic anaemia.再生障碍性贫血
Lancet. 2005;365(9471):1647-56. doi: 10.1016/S0140-6736(05)66515-4.
Zotero 插件